Skip to content

The Regulatory Role of Immune Response in Oral Lichen Planus

The Regulatory Role of Immune Response in Oral Lichen Planus With Mental Disorders

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05997173
Enrollment
90
Registered
2023-08-18
Start date
2020-09-07
Completion date
2025-02-28
Last updated
2023-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Oral Lichen Planus

Keywords

oral lichen planus, depression, anxiety, mesenchymal stem cells

Brief summary

Oral lichen planus (OLP) is a common chronic inflammatory disease of Oral mucosa. The pathogenesis of OLP is not clear, and there is no effective method to cure it. In vitro, previous studies have shown that oral mucosal mesenchymal stem cell cells (MSCs) can secrete Ido, which is involved in the pathogenesis of OLP. It has been proved that mental disorders such as depression and anxiety play an important role in the pathogenesis and treatment of OLP. Mental stress factors can cause abnormal changes of inflammatory factors, leading to immune dysfunction, which is also one of the main causes of OLP. In this study, we integrated the advantages of stomatology, psychiatry, neurobiology and traditional Chinese medicine, focused on the clinical problems of mental disorders with oral mucosal comorbidity, and assessed the depressive and anxiety status of OLP patients, so as to improve the therapeutic effect of OLP.

Interventions

OTHERControl

Investigation of scale of control

OTHERNon erosive OLP

Investigation of cale of non erosive OLP patients

OTHERErosive OLP

Investigation of cale of erosive OLP patients

Sponsors

Peking University Third Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_CROSSOVER
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* patients with oral lichen planus * male or female patients older than 18 years of age * patients willing to participate with signed informed consent.

Exclusion criteria

* pregnant or lactating * had serious systemic diseases of the heart, lung, liver, and kidney, or had tumors * were unwilling to participate in the experiment.

Design outcomes

Primary

MeasureTime frameDescription
The scores of the scale with the symptoms and signs of the diseaseDuring the initial diagnosis,through study completion, an average of 1 yearPsychological factors in OLP patients and normal controls were assessed using psychological scales such as the Hamilton Anxiety Scale (HAMA) and Hamilton Depression Scale (HAMD). Tissue and blood samples were collected during visits, and the concentrations of inflammatory factors in normal and lesion tissues were detected using immunofluorescence, flow cytometry, and enzyme-linked immunosorbent assay (ELISA). Statistical analysis was performed to determine the correlation between emotional disorders and inflammation in OLP patients, aiming to elucidate the underlying pathogenic mechanisms.

Secondary

MeasureTime frameDescription
Immune inflammatory responseDuring the initial diagnosis,through study completion, an average of 1 yearPsychological factors in OLP patients and normal controls were assessed using psychological scales such as the Hamilton Anxiety Scale (HAMA) and Hamilton Depression Scale (HAMD). Tissue and blood samples were collected during visits, and the concentrations of inflammatory factors in normal and lesion tissues were detected using immunofluorescence, flow cytometry, and enzyme-linked immunosorbent assay (ELISA). Statistical analysis was performed to determine the correlation between emotional disorders and inflammation in OLP patients, aiming to elucidate the underlying pathogenic mechanisms.

Countries

China

Contacts

Primary ContactZhihui Zhang
wisdomzhangzhihui@163.com010-82266125
Backup ContactLin Zeng

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026